BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4
39 results:

  • 1. Transcriptome analysis of an AKT inhibitor-resistant endometrial cancer cell line.
    Onishi T; Takashima T; Shibahara K; Takagi S; Tanaka S; Mori M; Odashima H; Osawa Y; Hattori M
    Pharmacol Rep; 2024 Apr; 76(2):379-389. PubMed ID: 38478219
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. col1a1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
    Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. col1a1::PDGFB fusion uterine sarcoma with a TERT promoter mutation.
    Lu Y; Chen X; Zeng W; Hua P; Shen Y; Qiu Y; He X; Zhang H
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23210. PubMed ID: 37870859
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EZH2 activates Wnt/β-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate.
    Ali M; Stone D; Laknaur A; Yang Q; Al-Hendy A
    F S Sci; 2023 Aug; 4(3):239-256. PubMed ID: 37182601
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pivotal Role of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) in uterine Leiomyoma.
    Suzuki T; Dai Y; Ono M; Kojima J; Sasaki T; Fujiwara H; Kuji N; Nishi H
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830563
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. col1a1-PDGFB Fusion Associated Fibrosarcoma of the uterine Corpus: A Case Report and Literature Review.
    Panwar V; Liu Y; Gwin K; Chen H
    Int J Gynecol Pathol; 2023 Mar; 42(2):143-146. PubMed ID: 36729934
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis.
    Wu Y; Wang F; Shi J; Guo X; Li F
    J Gynecol Oncol; 2023 Mar; 34(2):e19. PubMed ID: 36659830
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tandem mass tag-based quantitative proteomic analysis of cervical cancer.
    Aljawad MF; Faisal AHMA; Alqanbar MF; Wilmarth PA; Hassan BQ
    Proteomics Clin Appl; 2023 Jan; 17(1):e2100105. PubMed ID: 36029187
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Relugolix and elagolix directly inhibit leiomyoma extracellular matrix production in 2-dimesnional and 3-dimensional cell cultures.
    Wright D; Britten J; Malik M; Catherino WH
    F S Sci; 2022 Aug; 3(3):299-308. PubMed ID: 35977805
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Update on Mesenchymal Lesions of the Lower Female Genital Tract.
    Croce S; Perret R; Le Loarer F
    Surg Pathol Clin; 2022 Jun; 15(2):341-367. PubMed ID: 35715165
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Hop and artichoke extracts inhibit expression of extracellular matrix components in uterine leiomyoma cells.
    Islam MS; Greco S; Delli Carpini G; Giannubilo SR; Segars J; Ciavattini A; Ciarmela P
    F S Sci; 2021 Nov; 2(4):407-418. PubMed ID: 35559863
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Case of col1a1-PDGFB Fusion uterine Sarcoma.
    Hogeboom A; Bárcena C; Parrilla-Rubio L; Revilla E; Ruano Y; Gallego-Gutiérrez I; Martínez-López M
    Int J Gynecol Pathol; 2023 Mar; 42(2):147-150. PubMed ID: 35551153
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Discovering biomarkers for hormone-dependent tumors: in silico study on signaling pathways implicated in cell cycle and cytoskeleton regulation.
    Waszczykowska K; Prażanowska K; Kałuzińska Ż; Kołat D; Płuciennik E
    Mol Genet Genomics; 2022 Jul; 297(4):947-963. PubMed ID: 35532795
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long Noncoding RNA MIAT Modulates the Extracellular Matrix Deposition in Leiomyomas by Sponging MiR-29 Family.
    Chuang TD; Quintanilla D; Boos D; Khorram O
    Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34491311
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Variances in the Expression Profile of the EMT-Related Genes in Endometrial cancer Lines In Vitro Study.
    Nowakowski R; Grabarek B; Burnat-Olech A; Boroń D; Paul-Samojedny M
    Curr Pharm Biotechnol; 2022; 23(4):594-608. PubMed ID: 34225617
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tryptophan catabolism is dysregulated in leiomyomas.
    Chuang TD; Quintanilla D; Boos D; Khorram O
    Fertil Steril; 2021 Oct; 116(4):1160-1171. PubMed ID: 34116832
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
    Sahly NN; Banaganapalli B; Sahly AN; Aligiraigri AH; Nasser KK; Shinawi T; Mohammed A; Alamri AS; Bondagji N; Elango R; Shaik NA
    Syst Biol Reprod Med; 2021 Jun; 67(3):209-220. PubMed ID: 33685300
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. NTRK and other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms.
    Croce S; Hostein I; McCluggage WG
    Genes Chromosomes Cancer; 2021 Mar; 60(3):147-159. PubMed ID: 33099837
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis.
    Chuang TD; Rehan A; Khorram O
    Fertil Steril; 2021 Jan; 115(1):238-247. PubMed ID: 33070965
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.